Sparsomycin derivatives
AssigneeMerrell Dow Pharmaceuticals Inc.
InventorsDouglas W. Beight, Gary A. Flynn
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerrell Dow Pharmaceuticals Inc.
InventorsDouglas W. Beight, Gary A. Flynn
Estimating the term…
Sparsomycin derivatives of the formula ##STR1## wherein X and y are each independently an oxo or an imino group; n is O or the integer 1 or 2; R.sub.1 is a hydrogen or 1 to 4 carbon alkyl group; R.sub.2 is a hydrogen, a 1 to 4 carbon alkyl, a 2 to 5 carbon acyl or a benzoyl group; and R is a 1 to 6 carbon alkyl, 3 to 8 carbon alkenyl, cyanomethyl carboxymethyl, carbalkoxymethyl wherein the alkoxy moiety is a 1 to 4 carbon alkoxy group, nitromethyl, alkylcarbonylmethyl wherein the alkyl moiety is a 1 to 4 carbon alkyl group, pyridyl, furanyl, or furfuryl group or a phenyl or benzyl group optionally substituted by a methylenedioxy or one to two halogen, 1 to 4 carbon alkyl, 1 to 4 carbon alkoxy, 1 to 4 carbon alkylthio, hydroxy, nitro or cyano groups or a pharmaceutically acceptable acid addition salt thereof. Also described are their use as antiprotozoals and antibacterials.
The compound N-[1-(Hydroxymethyl)-2-[[4-(hydroxy)phenyl]sulfinyl]ethyl]-3-(6-methylurac il)-2-propenamide or a pharmaceutically acceptable salt thereof.
The compound D-N-[1-(Hydroxymethyl)-2-[[4-(hydroxy)phenyl]sulfinyl]ethyl]-3-(6-methylur acil)-2-propenamide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.